Options Trading Tutorial

Stock Options Trading News

Sun: Teva fall fails to stir flat marketSunday, July 17, 2011 @ 9:28AMPartner continued to fall on concerns about Ilan Ben-Dov, Cellcom also slipped but its was a good day for Bezeq.

SodaStream Options Signal Retreat After Rally: Israel OvernightSunday, July 17, 2011 @ 2:32AMOptions traders are boosting bets that SodaStream International Ltd. shares will fall after an eight-month rally in the Israeli producer of homemade soda machines pushed valuations to seven times the Standard & Poor’s 500 Index.

Consider taking stock in a buy-and-hold strategySunday, July 17, 2011 @ 12:09AMThe humbling lesson of the last quarter is that it's difficult to outsmart the stock or commodity markets.

Seattle Genetics Lymphoma Drug Recommended For FDA Approval With Additional TestingSaturday, July 16, 2011 @ 7:11PMSeattle Genetics blood cancer drug Adcetris, whose sales analysts say could reach $320 million, was recommended for approval Thursday by the Food and Drug Administration, the Associated Press reported. Adcetris treats patients with Hodgkin's disease and systemic anaplastic large cell lymphoma who are not responding to conventional treatments such as chemotherapy or stem cell transplants, or ...

In Mutual Fund Performance, Vice Battles VirtueSaturday, July 16, 2011 @ 1:29PMIn second-quarter performance, a mutual fund that follows virtuous investing landed on top. But a vice fund was nipping at its heels at No. 2.

Identifying a tipsy marketSaturday, July 16, 2011 @ 12:37PMAshwin was worried. His track record as a good stock picker was taking a knock. Of late, the prices of stocks he bought invariably dipped, while those he sold headed north.

The smart girl's guide to sharesSaturday, July 16, 2011 @ 9:00AMWITH a small amount of cash and some good advice, playing the stock market can give your bank balance a nice boost.

Derek Pain: Star-performing Booker's board worth every pennyFriday, July 15, 2011 @ 6:34PMInvestors are rightly appalled by boardroom greed. Particularly obnoxious is the culture that richly rewards mediocrity, even outright failure. But sometimes shareholder anger is misplaced. A prime example occurred last week – at the yearly meeting of Booker, the star of the No Pain, No Gain portfolio.

Earnings Preview: Charles Schwab Corp.Friday, July 15, 2011 @ 6:30PMDiscount broker and retirement plan provider Charles Schwab Corp. is expected to offer insight into whether it's overcoming a recent slump in trading activity by its clients when it reports its second-quarter earnings before the markets open Monday.